Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -172,871 | -173,482 | -118,476 | -78,253 | -62,949 |
| Depreciation Amortization | 615 | -31 | 143 | 522 | 552 |
| Other Working Capital | 25,372 | 27,666 | 8,569 | 8,777 | 2,066 |
| Other Operating Activity | 14,078 | 16,922 | 16,004 | 7,367 | 15,640 |
| Operating Cash Flow | $-132,806 | $-128,925 | $-93,760 | $-61,587 | $-44,690 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -587 | 1,270 | -8,206 | 29,500 | -24,644 |
| PPE Investments | -131 | -90 | -2 | -344 | -42 |
| Purchase Of Investment | N/A | N/A | N/A | -15,200 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 12,589 | N/A |
| Investing Cash Flow | $-718 | $1,180 | $-8,208 | $26,545 | $-24,686 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,987 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 175,021 | 113,639 | 133,659 | 5,029 | 68,828 |
| Other Financing Activity | -795 | 0 | 0 | -13 | -104 |
| Financing Cash Flow | $204,213 | $113,639 | $133,659 | $5,016 | $68,724 |
| Beginning Cash Position | 43,199 | 57,305 | 25,614 | 55,640 | 55,714 |
| End Cash Position | 113,888 | 43,199 | 57,305 | 25,614 | 55,061 |
| Net Cash Flow | $70,689 | $-14,106 | $31,691 | $-30,026 | $-653 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,806 | -128,925 | -93,760 | -61,587 | -44,690 |
| Capital Expenditure | -131 | -90 | -2 | -344 | -42 |
| Free Cash Flow | -132,937 | -129,015 | -93,762 | -61,931 | -44,733 |